AGP Executive Report
Last update: 2 hours agoApplied AI & governance: Ai4 2026 (Aug 4–6, Las Vegas) spotlights the shift from AI pilots to agentic systems that must be governed, authorized, and audited fast enough for real-world decisions. ADHD therapeutics: FDA approved Otsuka’s Simtriyo (centanafadine) for ADHD, with symptom improvements seen within week one across Phase 3 trials. Health tech R&D: Edinburgh spin-out Kāhu SiliconBio won £1.2m to build continuous hormone monitoring for better diagnosis of conditions like endometriosis and PCOS. Medical imaging: University of Saskatchewan researchers are developing a functional MRI approach to capture knee behavior under load and motion for earlier osteoarthritis detection. Biotech education & talent: Qatar won bronze at the 2026 International Biology Olympiad in Lithuania, backed by local training with Qatar University and Qatar Science and Technology School. Public safety & surveillance backlash: Flock Safety’s facial-recognition-style surveillance push faces growing contract cancellations and a planned week of action after concerns about data sharing and public risk. Trade facilitation: Kenya is watching China’s Xiamen reforms, which cut customs clearance time by 30% via digitized port operations and simplified procedures. Environment & infrastructure: Northern Indiana Commuter Transportation District approved a 20-year South Shore Line plan including rolling stock replacement and station relocation to reduce grade crossings.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.